Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare autosomal dominant inherited metabolic disorder characterized by deficiency of the enzyme tetrahydrofolate-methyltransferase. It results in the abnormal metabolism of methylcobalamin. Signs and symptoms include mental retardation, megaloblastic anemia, hypotonia, epilepsy, and hepatosplenomegaly.
No clinical trials have been registered for arakawa syndrome 2.
6 publications have been identified in PubMed for arakawa syndrome 2. Research spans Case Report / Case Series (67%), Other (17%), and Basic Science / Preclinical (17%).
Komori M (2025). [PMID: 40772180](https://pubmed.ncbi.nlm.nih.gov/40772180/). *Cureus*. [Case Report / Case Series]
Seki N (2025). [PMID: 40587904](https://pubmed.ncbi.nlm.nih.gov/40587904/). *J Neurosurg Case Lessons*. [Case Report / Case Series]
Ishida H (2025). [PMID: 40070605](https://pubmed.ncbi.nlm.nih.gov/40070605/). *Cureus*. [Case Report / Case Series]
Mima Y (2025). [PMID: 40196054](https://pubmed.ncbi.nlm.nih.gov/40196054/). *Cureus*. [Case Report / Case Series]
Arakawa I (2025). [PMID: 39977378](https://pubmed.ncbi.nlm.nih.gov/39977378/). *Crim Behav Ment Health*. [Other]
Gajawelli N (2024). [PMID: 38924235](https://pubmed.ncbi.nlm.nih.gov/38924235/). *Hum Brain Mapp*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 3:02 PM UTC
Genetic and Rare Diseases Info Center